AR and polycystic ovary syndrome: Studies performed on primary cultures of luteinized GC from large antral follicles of non-PCOS women indeed demonstrate the ability of testosterone to down-regulate CYP19A1 expression through the androgen receptor (AR) in a dose-dependent manner [90].